ACC/AHA/ESC 2006 guidelines for management of patients with
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
ACC/AHA/ESC Practice Guidelines
... Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and ...
... Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and ...
Recommendations for the Evaluation of Left Ventricular Diastolic
... for the maximum time for LV filling. This theoretically optimal situation is approached by the cyclic interaction of myofilaments and assumes competent mitral and aortic valves. Diastole starts at aortic valve closure and includes LV pressure fall, rapid filling, diastasis (at slower heart rates), a ...
... for the maximum time for LV filling. This theoretically optimal situation is approached by the cyclic interaction of myofilaments and assumes competent mitral and aortic valves. Diastole starts at aortic valve closure and includes LV pressure fall, rapid filling, diastasis (at slower heart rates), a ...
Cardiac Auscultation: Rediscovering the Lost Art
... certain maneuvers, eg, squatting, standing, and Valsalva (see below). Curr Probl Cardiol, July 2008 ...
... certain maneuvers, eg, squatting, standing, and Valsalva (see below). Curr Probl Cardiol, July 2008 ...
AHA Conference Proceedings
... and the potential benefits of revascularization for an individual patient. Renal revascularization does not consistently produce improvement in renal function and on occasion may lead to adverse events, including atheroembolization. Indeed, the foundation of the CORAL trial underscores the fact that ...
... and the potential benefits of revascularization for an individual patient. Renal revascularization does not consistently produce improvement in renal function and on occasion may lead to adverse events, including atheroembolization. Indeed, the foundation of the CORAL trial underscores the fact that ...
ACC/AHA/ESC 2006 Guidelines for Management of Patients With
... AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ ...
... AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ ...
ACC/AHA/ESC 2006 Guidelines for Management of
... AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ ...
... AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ ...
Revascularization to Improve Survival: Non
... Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective. *Data available from clinical trials or registri ...
... Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective. *Data available from clinical trials or registri ...
2011 ACCF/AHA Guidelines for Coronary Artery Bypass Graft
... Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective. *Data available from clinical trials or registri ...
... Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective. *Data available from clinical trials or registri ...
Committee papers
... readily available to people who will potentially benefit from sacubitril valsartan. It was aware that EF level is usually demonstrated with an echocardiogram and additional tests will not necessarily be required before initiating sacubitril valsartan.’ In the UK, operators who perform echocardiograp ...
... readily available to people who will potentially benefit from sacubitril valsartan. It was aware that EF level is usually demonstrated with an echocardiogram and additional tests will not necessarily be required before initiating sacubitril valsartan.’ In the UK, operators who perform echocardiograp ...
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the
... The writing committee gratefully acknowledges the memory of James T. Dove, MD, who died during the development of this document but contributed immensely to our understanding of stable ischemic heart disease. This document was approved by the American College of Cardiology Foundation Board of Truste ...
... The writing committee gratefully acknowledges the memory of James T. Dove, MD, who died during the development of this document but contributed immensely to our understanding of stable ischemic heart disease. This document was approved by the American College of Cardiology Foundation Board of Truste ...
Factors influencing the spontaneous closure of ventricular septal
... Ventricular septal defect (VSD) is the most common congenital heart defect, which accounts for 20%-42.86% of all congenital heart diseases (CHD) [1-3]. The incidence of VSD is approximately 1.35 to 17.3 per 1000 live births [4, 5]. Some of these defects can close spontaneously, or diminish without s ...
... Ventricular septal defect (VSD) is the most common congenital heart defect, which accounts for 20%-42.86% of all congenital heart diseases (CHD) [1-3]. The incidence of VSD is approximately 1.35 to 17.3 per 1000 live births [4, 5]. Some of these defects can close spontaneously, or diminish without s ...
MOTETE_2013 - Durban University of Technology
... Fifty consecutive patients with pericarditis presenting to Groote Schuur Hospital and surrounding hospitals referred for pericardiocentesis, who met the inclusion criteria were recruited to participate in the study. All patients had the right atrial and intrapericardial pressures simultaneously meas ...
... Fifty consecutive patients with pericarditis presenting to Groote Schuur Hospital and surrounding hospitals referred for pericardiocentesis, who met the inclusion criteria were recruited to participate in the study. All patients had the right atrial and intrapericardial pressures simultaneously meas ...
Print - Circulation Research
... organ bath by means of two metal holders, one being anchored and the other being connected to a force displacement transducer (model TB-612T, Nihon Kohden) for the measurement of isometric contractions. The solution was constantly bubbled with a mixture of 95% 02-5% CO2 and kept at 37°C. The resting ...
... organ bath by means of two metal holders, one being anchored and the other being connected to a force displacement transducer (model TB-612T, Nihon Kohden) for the measurement of isometric contractions. The solution was constantly bubbled with a mixture of 95% 02-5% CO2 and kept at 37°C. The resting ...
Influence of Ejection Fraction on the Prognostic Value of
... few measures are available to risk-stratify HF patients with a normal or mildly reduced LVEF. In particular, although subjects with HF and an LVEF ⬎35% are at an increased risk of sudden death compared with persons without HF, there is currently no widely applicable method to risk-stratify these pat ...
... few measures are available to risk-stratify HF patients with a normal or mildly reduced LVEF. In particular, although subjects with HF and an LVEF ⬎35% are at an increased risk of sudden death compared with persons without HF, there is currently no widely applicable method to risk-stratify these pat ...
Evaluation of Syncope
... have coronary artery or cerebrovascular disease and to take cardiac or antihypertensive medications than patients without syncope.1 Medications that affect cardiac conduction are a potential cause of syncope, and arrhythmias may be induced despite nontoxic blood levels. Compared with all other patie ...
... have coronary artery or cerebrovascular disease and to take cardiac or antihypertensive medications than patients without syncope.1 Medications that affect cardiac conduction are a potential cause of syncope, and arrhythmias may be induced despite nontoxic blood levels. Compared with all other patie ...
Enhanced Resistance to Permeability Transition in - AJP
... Articles in PresS. Am J Physiol Heart Circ Physiol (December 15, 2012). doi:10.1152/ajpheart.00674.2012 Asemu et al, H-00674-2012 Revision 2 ...
... Articles in PresS. Am J Physiol Heart Circ Physiol (December 15, 2012). doi:10.1152/ajpheart.00674.2012 Asemu et al, H-00674-2012 Revision 2 ...
Myocardial ischemia-reperfusion injury
... infarct-related coronary artery, there is still no effective therapy for preventing myocardial reperfusion injury. In this respect, myocardial reperfusion injury remains a neglected therapeutic target for cardioprotection in PPCI patients. In this article, the pathophysiology of myocardial lRI and t ...
... infarct-related coronary artery, there is still no effective therapy for preventing myocardial reperfusion injury. In this respect, myocardial reperfusion injury remains a neglected therapeutic target for cardioprotection in PPCI patients. In this article, the pathophysiology of myocardial lRI and t ...
2011 ACCF/AHA Guidelines for Coronary Artery Bypass Graft Surgery
... the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective. *Data available from clinical trials or registries about the usefulness/efficacy in different s ...
... the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective. *Data available from clinical trials or registries about the usefulness/efficacy in different s ...
Practice Guideline
... the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools. The American College of Cardiology ...
... the best management strategy for an individual patient. Moreover, clinical practice guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools. The American College of Cardiology ...
Prognosis of Adults With Borderline Left Ventricular Ejection Fraction
... OBJECTIVES This study sought to examine the association of a borderline left ventricular ejection fraction (LVEF) of 50% to 55% with cardiovascular morbidity and mortality in a community-based cohort. BACKGROUND Guidelines stipulate a LVEF >55% as normal, but the optimal threshold, if any, remains u ...
... OBJECTIVES This study sought to examine the association of a borderline left ventricular ejection fraction (LVEF) of 50% to 55% with cardiovascular morbidity and mortality in a community-based cohort. BACKGROUND Guidelines stipulate a LVEF >55% as normal, but the optimal threshold, if any, remains u ...
Ch_22_lecture_presentation
... • In areas such as the brain, heart, and stomach, a continuous, rich flow of blood is required • In these areas, more than one artery supplies a specific area • These arteries (collateral arteries) typically fuse forming an arterial anastomosis • If one arteriole is blocked, the other one will suppl ...
... • In areas such as the brain, heart, and stomach, a continuous, rich flow of blood is required • In these areas, more than one artery supplies a specific area • These arteries (collateral arteries) typically fuse forming an arterial anastomosis • If one arteriole is blocked, the other one will suppl ...
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the
... diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography ...
... diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography ...
Quantitative Imaging of Diastolic Function using Cardiac Magnetic
... pressure gradients. Mitral blood velocity and flow were found to have distinct time-courses that become more similar with increasing severity of diastolic dysfunction. Velocity propagation, a wave-like pressure wave phenomenon, was observed in the left atrium during systole, early filling and atrial ...
... pressure gradients. Mitral blood velocity and flow were found to have distinct time-courses that become more similar with increasing severity of diastolic dysfunction. Velocity propagation, a wave-like pressure wave phenomenon, was observed in the left atrium during systole, early filling and atrial ...
Chapter 7 - Introduction to Composite Endpoints
... patient is likely to experience all of them. These types of component endpoints we will term coincident endpoints. If a patient experiences one of two coincident endpoints, they are likely to experience the other. In this situation, there is no real advantage in using the combined endpoint instead o ...
... patient is likely to experience all of them. These types of component endpoints we will term coincident endpoints. If a patient experiences one of two coincident endpoints, they are likely to experience the other. In this situation, there is no real advantage in using the combined endpoint instead o ...
Antihypertensive drug
Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischaemic heart disease by 21%, and reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used drugs are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.Which type of medication to use initially for hypertension has been the subject of several large studies and resulting national guidelines. The fundamental goal of treatment should be the prevention of the important endpoints of hypertension, such as heart attack, stroke and heart failure. Patient age, associated clinical conditions and end-organ damage also play a part in determining dosage and type of medication administered. The several classes of antihypertensives differ in side effect profiles, ability to prevent endpoints, and cost. The choice of more expensive agents, where cheaper ones would be equally effective, may have negative impacts on national healthcare budgets. As of 2009, the best available evidence favors the thiazide diuretics as the first-line treatment of choice for high blood pressure when drugs are necessary. Although clinical evidence shows calcium channel blockers and thiazide-type diuretics are preferred first-line treatments for most people (from both efficacy and cost points of view), an ACE inhibitor is recommended by NICE in the UK for those under 55 years old.